<SEC-DOCUMENT>0001062993-22-018607.txt : 20220823
<SEC-HEADER>0001062993-22-018607.hdr.sgml : 20220823
<ACCEPTANCE-DATETIME>20220823091348
ACCESSION NUMBER:		0001062993-22-018607
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20220822
FILED AS OF DATE:		20220823
DATE AS OF CHANGE:		20220823

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IM Cannabis Corp.
		CENTRAL INDEX KEY:			0001792030
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40065
		FILM NUMBER:		221185163

	BUSINESS ADDRESS:	
		STREET 1:		1 ADELAIDE STREET EAST, UNIT 801
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5C 2V9
		BUSINESS PHONE:		416-256-4202

	MAIL ADDRESS:	
		STREET 1:		1 ADELAIDE STREET EAST, UNIT 801
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5C 2V9
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>form6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<html>

<head>
    <title>IM Cannabis Corp.: Form 6-K - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade">
    <p style="text-align: center;"><font style="font-size: 18pt;"><b>UNITED STATES</b></font><br><font style="font-size: 18pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></font><br>Washington, D.C. 20549<br><br><font style="font-size: 18pt;"><b>Form 6-K</b></font><br><br><b>REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16</b><br><b>UNDER THE SECURITIES EXCHANGE ACT OF 1934</b></p>
    <p style="text-align: justify;">For the month of <u><b>August, 2022.</b></u></p>
    <p style="margin-bottom: 0pt; text-align: justify;">Commission File Number: <u><b>001-40065</b></u></p>
    <p style="margin-top: 0pt; text-align: center;"><br><br><font style="font-size: 18pt;"><u><b>IM Cannabis Corp.</b></u></font><br>(Exact Name of Registrant as Specified in Charter)<br><br><u><b>Kibbutz Glil Yam, Central District, Israel 4690500</b></u><br>(Address of principal executive offices)</p>
    <p style="margin-bottom: 0pt; text-align: justify;">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</p>
    <p style="margin-top: 0pt; text-align: justify;">Form 20-F&#160; &#9633;&#160; Form 40-F &#8864;</p>
    <p style="text-align: justify;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____</p>
    <p style="text-align: justify;"><b>Note</b>: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.</p>
    <p style="text-align: justify;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____</p>
    <p style="text-align: justify;"><b>Note</b>: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade">
    <p style="text-align: center;"><b>SIGNATURE</b></p>
    <p style="text-indent: 36pt; text-align: justify;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 50%;">&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt;" colspan="2"><b>IM CANNABIS CORP.</b></td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 50%;">&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt;" colspan="2">(Registrant)</td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 50%;">&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 5%;">&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 45%;">&#160;</td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 50%;">Date: August 23, 2022</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 5%; border-bottom: 0.75pt solid #000000;">By:</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 45%; border-bottom: 0.75pt solid #000000;"><i>/s/ Oren Shuster</i></td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 50%;">&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 5%;">Name:&#160;&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 45%;">Oren Shuster</td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 50%;">&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 5%;">Title:</td>
            <td style="margin-bottom: 0pt; width: 45%;">Chief Executive Officer and Director</td>
        </tr>
    </table>
    <br>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade">
    <p style="text-align: center;"><u><b>EXHIBIT INDEX</b></u></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 10%; background-color: #eeeeee;">
                <p><a href="exhibit99-1.htm">99.1</a></p>
            </td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 90%; background-color: #eeeeee;">
                <p><a href="exhibit99-1.htm">Form 6 - Certificate of Compliance dated August 22, 2022</a></p>
            </td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 10%;">&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 90%;">&#160;</td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 10%; background-color: #eeeeee;"><a href="exhibit99-2.htm">99.2</a></td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 90%; background-color: #eeeeee;"><a href="exhibit99-2.htm">Form 10 - Notice of Proposed Significant Transaction dated August 22, 2022</a></td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 10%;">&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 90%;">&#160;</td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 10%; background-color: #eeeeee;"><a href="exhibit99-3.htm">99.3</a></td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 90%; background-color: #eeeeee;"><a href="exhibit99-3.htm">Receipt of Proceeds of Sale dated August 22, 2022</a></td>
        </tr>
    </table>
    <br>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>

<head>
    <title>IM Cannabis Corp.: Exhibit 99.1 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade">
    <p style="text-align: center;"><font style="font-size: 12pt;"><b>FORM 6</b></font></p>
    <p style="text-align: center;"><font style="font-size: 12pt;"><u><b>CERTIFICATE OF COMPLIANCE</b></u></font></p>
    <p style="text-align: justify;"><b>TO:</b><font style="width: 15.34pt; display: inline-block;">&#160;</font><b>CANADIAN SECURITIES EXCHANGE ("CSE")</b></p>
    <p style="text-align: justify;"><u>IM Cannabis Corp.</u><b> </b>(the "Listed Issuer") hereby certifies to CSE that the Issuer is in compliance with the requirements of applicable securities legislation (as such term is defined in National Instrument 14-101) and all Exchange Requirements (as defined in Policy 1).</p>
    <table style="width: 97.9122%; font-size: 10pt; border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 50%;">&#160;</td>
            <td colspan="2">&#160;</td>
        </tr>
        <tr>
            <td>&#160;</td>
            <td style="width: 5%;">Date:</td>
            <td style="border-bottom: 0.75pt solid #000000;">August 22, 2022</td>
        </tr>
        <tr>
            <td>&#160;</td>
            <td>&#160;</td>
            <td>&#160;</td>
        </tr>
        <tr>
            <td>&#160;</td>
            <td>Signed:</td>
            <td style="border-bottom: 0.75pt solid #000000;">"<i>Oren Shuster</i>"</td>
        </tr>
        <tr>
            <td>&#160;</td>
            <td>&#160;</td>
            <td>(Signature)</td>
        </tr>
        <tr>
            <td>&#160;</td>
            <td>&#160;</td>
            <td>&#160;</td>
        </tr>
        <tr>
            <td>&#160;</td>
            <td>&#160;</td>
            <td style="border-bottom: 0.75pt solid #000000;">Oren Shuster</td>
        </tr>
        <tr>
            <td>&#160;</td>
            <td>&#160;</td>
            <td>(Print Name)</td>
        </tr>
        <tr>
            <td>&#160;</td>
            <td>&#160;</td>
            <td>&#160;</td>
        </tr>
        <tr>
            <td>&#160;</td>
            <td>&#160;</td>
            <td style="border-bottom: 0.75pt solid #000000;">Chief Executive Officer</td>
        </tr>
        <tr>
            <td>&#160;</td>
            <td>&#160;</td>
            <td>(Print Office)</td>
        </tr>
    </table>
    <div>
        <p style="margin-bottom: 0pt; text-align: center;"><b><br></b></p>
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%; border-top: 0.75pt solid #000000;">&#160;</td>
            </tr>
            <tr>
                <td style="width: 100%;">
                    <p style="margin-bottom: 0pt; text-align: center;"><b>FORM 6 - CERTIFICATE OF COMPLIANCE</b></p>
                    <p style="margin-top: 0pt; text-align: center;">January 2015</p>
                </td>
            </tr>
        </table>
        <br>
    </div>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>exhibit99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<html>

<head>
    <title>IM Cannabis Corp.: Exhibit 99.2 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <div><br></div>
    <p style="text-align: center;"><b><font style="font-size: 12pt;">FORM 10</font></b><br><br><font style="font-size: 12pt;"><b>NOTICE OF PROPOSED SIGNIFICANT TRANSACTION (not involving <br></b><u><b>an issuance or potential issuance of a listed security)</b></u></font><a name="_ftnref1"></a><font style="font-size: 12pt;"><a style="text-decoration: none;" href="#_ftn1"><font style="color: #000000;"><sup><u><b>1</b></u></sup></font></a></font></p>
    <p style="text-align: justify;">Name of Listed Issuer: <u>IM Cannabis Corp.</u> (the "Issuer")</p>
    <p style="text-align: justify;">Trading Symbol: <u>IMCC</u></p>
    <p style="text-align: justify;">Issued and Outstanding Securities of the Issuer Prior to Transaction: <u>69,695,325</u></p>
    <p style="text-align: justify;">Date of News Release Fully Disclosing the Transaction: <u>Not applicable</u></p>
    <p style="margin-left: 54pt; text-indent: -54pt; text-align: justify;"><b>1.</b><font style="width: 47.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Transaction</b></p>
    <p style="margin-left: 54pt; text-indent: -54pt; text-align: justify;">1.<font style="width: 46.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>Provide details of the transaction including the date, description&#160; and location of assets, if applicable, parties to and type of agreement (eg: sale, option, license, contract for Investor Relations Activities etc.) and relationship to the Issuer. The disclosure should be sufficiently complete to enable a reader to appreciate the significance of the transaction without reference to any other material:</p>
    <p style="margin-left: 54pt; text-align: justify;"><u>On August 5, 2022, the Issuer's subsidiary, Trichome JWC Acquisition Corp. ("TJAC") entered into a share purchase agreement (the "SPA") to sell 100% of the shares of its subsidiary, SublimeCulture Inc. ("Sublime") on an "as-is, where is" basis to a numbered company owned in part by a member of the Sublime management team and former employees and consultants of the Issuer's subsidiary, MYM Nutraceuticals Inc.. Sublime is a Related Person of the Issuer. Closing of the SPA resulted in the sale of all the shares of Sublime, and its related operations and obligations, including a leased facility based in Laval, Quebec, for the net purchase price of $88,901.83 ($100,000 less working capital adjustments per Section 2 below).&#160; The facility at Sublime was primarily used by the Issuer for the purpose of storage of inventory and supplies, as well as some small-scale cultivation.</u></p>
    <p style="margin-left: 54pt; text-indent: -54pt; text-align: justify;">2.<font style="width: 46.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>Provide the following information in relation to the total consideration for the transaction (including details of all cash, non-convertible debt securities or other consideration) and any required work commitments:</p>
    <div id="ftn_page_1">
        <hr style="width: 33%; height: 1px; background-color: #000000; text-align: left; margin-left: 0px;">
        <div id="_ftn1">
            <p style="text-align: justify; margin-top: 0px; margin-bottom: 0px;"><a style="text-decoration: none;" href="#_ftnref1"><font style="color: #000000;"><sup>1</sup></font></a> If the transaction involved the issuance of securities, other than debt securities that are not convertible into listed securities, use Form 9.</p>
        </div>
    </div>
    <br>
    <div id="footer_page_1">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%; border-top: 0.75pt solid #000000; padding-top: 10pt;">
                    <p style="margin-bottom: 0pt; text-align: center;"><b>FORM 10 - NOTICE OF PROPOSED</b></p>
                    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>SIGNIFICANT TRANSACTION</b></p>
                    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;">January2015</p>
                    <p style="margin-top: 0pt; text-align: center;">Page 1</p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_2"></a>
    <p style="margin-left: 108pt; text-indent: -54pt; text-align: justify;">(a)<font style="width: 42.33pt; text-indent: 0pt; display: inline-block;">&#160;</font>Total aggregate consideration in Canadian dollars: <u>$100,000 less working capital adjustments for a final net purchase price of $88,901.83.</u></p>
    <p style="margin-left: 108pt; text-indent: -54pt; text-align: justify;">(b)<font style="width: 41.83pt; text-indent: 0pt; display: inline-block;">&#160;</font>Cash: <u>$88,901.83.</u></p>
    <p style="margin-left: 108pt; text-indent: -54pt; text-align: justify;">(c)<font style="width: 42.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>Other: <u>None.</u></p>
    <p style="margin-left: 108pt; text-indent: -54pt; text-align: justify;">(d)<font style="width: 41.83pt; text-indent: 0pt; display: inline-block;">&#160;</font>Work commitments: <u>None.</u></p>
    <p style="margin-left: 54pt; text-indent: -54pt; text-align: justify;">3.<font style="width: 45.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>State how the purchase or sale price and the terms of any agreement were determined (e.g. arm's-length negotiation, independent committee of the Board, third party valuation etc).</p>
    <p style="margin-left: 54pt; text-align: justify;"><u>The purchase price was determined through negotiations with the prospective purchasers.</u></p>
    <p style="margin-left: 54pt; text-indent: -54pt; text-align: justify;">4.<font style="width: 46.49pt; text-indent: 0pt; display: inline-block;">&#160;</font>Provide details of any appraisal or valuation of the subject of the transaction known to management of the Issuer: <u>None.</u></p>
    <p style="margin-left: 54pt; text-indent: -54pt; text-align: justify;">5.<font style="width: 45.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>If the transaction is an acquisition, details of the steps taken by the Issuer to ensure that the vendor has good title to the assets being acquired: <u>N/A.</u></p>
    <p style="margin-left: 54pt; text-indent: -54pt; text-align: justify;">6.<font style="width: 45.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>Provide the following information for any agent's fee, commission, bonus or finder's fee, or other compensation paid or to be paid in connection with the transaction (including warrants, options, etc.):</p>
    <p style="margin-left: 108pt; text-indent: -54pt; text-align: justify;">(a)<font style="width: 42.83pt; text-indent: 0pt; display: inline-block;">&#160;</font>Details of any dealer, agent, broker or other person receiving compensation in connection with the transaction (name, address. If a corporation, identify persons owning or exercising voting control over 20% or more of the voting shares if known to the Issuer): <u>None.</u></p>
    <p style="margin-left: 108pt; text-indent: -54pt; text-align: justify;">(b)<font style="width: 42.83pt; text-indent: 0pt; display: inline-block;">&#160;</font>Cash ________________________________________________________________ .</p>
    <p style="margin-left: 108pt; text-indent: -54pt; text-align: justify;">(c)<font style="width: 43.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>Other ________________________________________________________________ .</p>
    <p style="margin-left: 54pt; text-indent: -54pt; text-align: justify;">7.<font style="width: 45.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>State whether the vendor, sales agent, broker or other person receiving compensation in connection with the transaction is a Related Person or has any other relationship with the Issuer and provide details of the relationship. <u>N/A.</u></p>
    <div id="footer_page_2">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%; border-top: 0.75pt solid #000000; padding-top: 10pt;">
                    <p style="margin-bottom: 0pt; text-align: center;"><b>FORM 10 - NOTICE OF PROPOSED</b></p>
                    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>SIGNIFICANT TRANSACTION</b></p>
                    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;">January2015</p>
                    <p style="margin-top: 0pt; text-align: center;">Page 2</p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_3"></a>
    <p style="margin-left: 54pt; text-indent: -54pt; text-align: justify;">8.<font style="width: 45.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>If applicable, indicate whether the transaction is the acquisition of an interest in property contiguous to or otherwise related to any other asset acquired in the last 12 months. <u>N/A.</u></p>
    <p style="margin-left: 54pt; text-indent: -54pt; text-align: justify;"><b>2.</b><font style="width: 45.99pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Development</b></p>
    <p style="text-align: justify;">Provide details of the development.&#160; The disclosure should be sufficiently complete to enable a reader to appreciate the significance of the transaction without reference to any other material:</p>
    <p style="text-align: justify;"><u>Please see Section 1 above. </u></p>
    <div id="footer_page_3">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%; border-top: 0.75pt solid #000000; padding-top: 10pt;">
                    <p style="margin-bottom: 0pt; text-align: center;"><b>FORM 10 - NOTICE OF PROPOSED</b></p>
                    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>SIGNIFICANT TRANSACTION</b></p>
                    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;">January2015</p>
                    <p style="margin-top: 0pt; text-align: center;">Page 3</p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_4"></a>
    <p style="text-align: justify;"><b>3.</b><font style="width: 25.99pt; display: inline-block;">&#160;</font><b>Certificate Of Compliance</b></p>
    <p style="text-align: justify;">The undersigned hereby certifies that:</p>
    <p style="margin-left: 54pt; text-indent: -54pt; text-align: justify;">1.<font style="width: 46.49pt; text-indent: 0pt; display: inline-block;">&#160;</font>The undersigned is a director and/or senior officer of the Issuer and has been duly authorized by a resolution of the board of directors of the Issuer to sign this Certificate of Compliance.</p>
    <p style="margin-left: 54pt; text-indent: -54pt; text-align: justify;">2.<font style="width: 46.49pt; text-indent: 0pt; display: inline-block;">&#160;</font>To the knowledge of the Issuer, at the time an agreement in principle was reached, no party to the transaction had knowledge of any undisclosed material information relating to the Issuer, other than in relation to the transaction.</p>
    <p style="margin-left: 54pt; text-indent: -54pt; text-align: justify;">3.<font style="width: 46.49pt; text-indent: 0pt; display: inline-block;">&#160;</font>As of the date hereof there is no material information concerning the Issuer which has not been publicly disclosed.</p>
    <p style="margin-left: 54pt; text-indent: -54pt; text-align: justify;">4.<font style="width: 46.49pt; text-indent: 0pt; display: inline-block;">&#160;</font>The undersigned hereby certifies to the Exchange that the Issuer is in compliance with the requirements of applicable securities legislation (as such term is defined in National Instrument 14-101) and all Exchange Requirements (as defined in CNSX Policy 1).</p>
    <p style="margin-left: 54pt; text-indent: -54pt; text-align: justify;">5.<font style="width: 46.49pt; text-indent: 0pt; display: inline-block;">&#160;</font>All of the information in this Form 10 Notice of Proposed Significant Transaction is true.</p>
    <p style="text-align: justify;">Dated <u>August 22, 2022</u>.</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 50%;">&#160;</td>
            <td style="width: 50%; border-bottom: 0.75pt solid #000000;">Oren Shuster</td>
        </tr>
        <tr>
            <td style="width: 50%;">&#160;</td>
            <td style="width: 50%;">Name of Director or Senior Officer</td>
        </tr>
        <tr>
            <td style="width: 50%;">&#160;</td>
            <td style="width: 50%;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 50%;">&#160;</td>
            <td style="width: 50%; border-bottom: 0.75pt solid #000000;">"<i>Oren Shuster</i>" <u><br></u></td>
        </tr>
        <tr>
            <td style="width: 50%;">&#160;</td>
            <td style="width: 50%;">Signature</td>
        </tr>
        <tr>
            <td style="width: 50%;">&#160;</td>
            <td style="width: 50%;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 50%;">&#160;</td>
            <td style="width: 50%; border-bottom: 0.75pt solid #000000;">Chief Executive Officer</td>
        </tr>
        <tr>
            <td style="width: 50%;">&#160;</td>
            <td style="width: 50%;">Official Capacity</td>
        </tr>
    </table>
    <div><br></div>
    <div id="footer_page_4">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%; border-top: 0.75pt solid #000000; padding-top: 10pt;">
                    <p style="margin-bottom: 0pt; text-align: center;"><b>FORM 10 - NOTICE OF PROPOSED</b></p>
                    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>SIGNIFICANT TRANSACTION</b></p>
                    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;">January2015</p>
                    <p style="margin-top: 0pt; text-align: center;">Page 4</p>
                </td>
            </tr>
        </table>
    </div>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>exhibit99-3.htm
<DESCRIPTION>EXHIBIT 99.3
<TEXT>
<html>

<head>
    <title>IM Cannabis Corp.: Exhibit 99.3 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade">
    <div>
        <p style="text-align: justify;"><img src="exhibit99-3x001.jpg" style="width: 124px;" height="78"></p>
    </div>
    <p style="text-align: justify;">August 22, 2022</p>
    <p style="margin-bottom: 0pt; text-align: justify;">Canadian Securities Exchange</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;">First Canadian Place</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;">100 King Street West, Suite 7210</p>
    <p style="margin-top: 0pt; text-align: justify;">Toronto, ON M5X 1E1</p>
    <p style="text-align: justify;">To Whom It May Concern:</p>
    <p style="text-align: justify;"><b>Re: IM Cannabis Corp. (the "Company") Sale of SublimeCulture Inc. ("Sublime")</b></p>
    <p style="text-align: justify;">On August 5, 2022, the Company completed the sale of Sublime to a group of purchasers that included current and former members of the Sublime management team for aggregate proceeds of $100,000 less working capital adjustments, for a final net purchase price of $88,901.83. The Company confirms the receipt of proceeds from the sale.</p>
    <p style="text-align: justify;">Yours truly,</p>
    <p style="text-align: justify;">IM Cannabis Corp.</p>
    <p style="text-align: justify;">"<i>Oren Shuster</i>"</p>
    <p style="margin-bottom: 0pt; text-align: justify;">Oren Shuster</p>
    <p style="margin-top: 0pt; text-align: justify;">Chief Executive Officer<br><br></p>
    <div>
        <p style="margin-bottom: 0pt; text-align: center;"><font style="color: #382f2d;">Beit Hakshatot, Kibutz Glil-Yam, ISRAEL, 4690500.Tell: 972-77-4442333<font style="display: inline-block; width: 6pt;">&#160;</font><b>|<font style="display: inline-block; width: 6pt;">&#160;</font></b>Fax: 972-77-4442332</font></p>
        <p style="margin-top: 0pt; text-align: center;"><font style="color: #382f2d;">www.imcannabis.com<font style="display: inline-block; width: 6pt;">&#160;</font><b>|<font style="display: inline-block; width: 6pt;">&#160;</font></b>info@imcannabis.com</font></p>
    </div>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>exhibit99-3x001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-3x001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  0" P,# @0# P,$! 0$!0D&!04%
M!0L(" 8)#0L-#0T+# P.$!01#@\3#PP,$A@2$Q46%Q<7#A$9&QD6&A06%Q;_
MVP!# 00$! 4%!0H&!@H6#PP/%A86%A86%A86%A86%A86%A86%A86%A86%A86
M%A86%A86%A86%A86%A86%A86%A86%A;_P  1" !. 'P# 2(  A$! Q$!_\0
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M/#OAFZM\_-%'#-&V/]EO,./Q!KZ;_9K_ &B_!GQ>']G6ZR:/KZ)N?3+EPWF
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M?V6_@EXB^+GC*".*UFMO#]M*#J.I,F(U4<E$)X9SZ#IG)XK[HTG]EWX%:=J
MNX/ =O)(IR%N;RXGC_[X>0K^E>JZ/INGZ3IT6GZ78V]E:0+MB@MXA''&/0*.
M!241NIV$T+3;/1]%M-)TZ%8;2Q@2""->B(H"@?D*MT459D%%%% !1110 444
<4 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
